Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
World Journal of Surgical Oncology
Published in: World Journal of Surgical Oncology 1/2005

Open Access 01-12-2005 | Research

Core biopsy as a tool in planning the management of invasive breast cancer

Authors: Amar Deshpande, Trivikram Garud, Simon D Holt

Published in: World Journal of Surgical Oncology | Issue 1/2005

Login to get access

Abstract

Background

Core biopsy is a method of choice for the triple assessment of breast disease as it can reliably distinguish between benign and malignant tumours, between in-situ and invasive cancers and can be useful to assess oestrogen receptor status. This study was carried out to assess the reliability of core biopsy in predicting the grade and type of cancer accurately as obtaining this information can influence initial therapeutic decisions.

Patients and methods

A total of 105 patients who had invasive breast carcinoma diagnosed by core biopsy in year 2001 and who subsequently underwent surgical management were included. The core biopsy results were compared with final histology with the help of kappa statastics.

Results

A moderate level of agreement between the predicted grades and final grades was noted (kappa = 0.585). The agreement was good between predicted and final type of tumour (kappa = 0.639).

Conclusions

Core biopsy as a predictor of grade and type has limited use at present. We suggest that initial clinical decisions should not be based on the results of core biopsy.
Literature
1.
Farshid G, Rush G: The use of fine-needle aspiration cytology and core biopsy in the assessment of highly suspicious mammographic calcifications: analysis of outcome for 182 lesions detected in the setting of a population-based breast cancer screening program. Cancer. 2003, 99: 357-364. 10.1002/cncr.11785.CrossRefPubMed
2.
Fersis N, Smyczek-Garagya B, Krainick U, Mielke G, Muller-Schimpfle M, Keisel L, Wallweiner D: Clinical experience with large-core needle biopsies of the breast and treatment and evaluation of histopathological results. Zentralbl Gynakol. 2001, 123: 132-135. 10.1055/s-2001-12509.CrossRefPubMed
3.
Clarke D, Sudhakaran N, Gately CA: Replace the fine needle aspiration cytologywith automated core biopsy in triple assessment of breast cancers. Ann R Coll Surg Engl. 2001, 83: 110-112.PubMedCentralPubMed
4.
Sun W, Li A, Abreo F, Turbat-Herrera E, Grafton WD: Comparison of fine needle aspiration cytology and core biopsy for diagnosis of breast cancer. Diagn Cytopathol. 2001, 24: 421-425. 10.1002/dc.1092.CrossRefPubMed
5.
Crowe JP, Rim A, Patrick RJ, Rybicki LA, Grundfest-Broniatowski SF, Kim JA, Lee KB: Does core needle breast biopsy accurately reflect breast pathology?. Surgery. 2003, 134: 523-528. 10.1016/S0039-6060(03)00269-1.CrossRefPubMed
6.
McIntosh SA, Panchalingam L, Payne S, Miller ID, Sarkar TK, Hutcheon AW, Heys SD: Freehand core biopsy in breast cancer: an accurate predictor of tumour grade following neo-adjuvant chemotherapy?. Breast. 2002, 11: 496-500. 10.1054/brst.2002.0466.CrossRefPubMed
7.
du Toit RS, Locker AP, Ellis IO, Elston CW, Nicholson RI, Blamey RW: Invasive lobular carcinomas of the breast- the prognosis of histopathological subtypes. Br J Cancer. 1989, 60: 605-609.PubMedCentralCrossRefPubMed
8.
Fisher ER, Redmond C, Fisher B: Prognostic factors in NSABP studies of women with node negative breast cancer. National Surgical Adjuvant Breast and Bowel project. Monogr Natl Cancer Inst. 1992, 11: 151-158.PubMed
9.
Dixon JM, Page DL, Anderson TJ, Lee D, Elton RA, Stewart HJ, Forest AP: Long-term survivors after breast cancer. Br J Surg. 1985, 72: 445-448.CrossRefPubMed
10.
Haybittle JL, Blamey RW, Elston CW, Johnson J, Doyle PJ, Campbell FC, Nicholson RI, Griffiths K: A prognostic index in primary breast cancer. Br J Cancer. 1982, 45: 361-365.PubMedCentralCrossRefPubMed
11.
Fajardo LL, Pisano ED, Caudry DJ, Gatsonis CA, Berg WA, Connolly J, Schnitt S, Page DL, McNeil BJ: Radiologist Investigators of the Radiologic Diagnostic Oncology Group V. Acad Radiol. 2004, 11: 293-308. 10.1016/S1076-6332(03)00510-5.CrossRefPubMed
12.
Shah VI, Raju U, Chitale D, Deshpande V, Gregory N, Strand V: False negative core biopsies of breast: an analysis of clinical, radiologic and pathologic findings in 27 consecutive cases of missed breast cancer. Cancer. 2003, 97: 1824-1831. 10.1002/cncr.11278.CrossRefPubMed
13.
Wong TE, Hisham AN: Core biopsy of palpable breast lump: the influence of needle size. Med J Malaysia. 2003, 58: 399-404.PubMed
14.
O'Leary R, Hawkins K, Beazley JC, Lansdown MR, Hanby AM: Agreement between preoperative and postoperative invasive breast cancer histopathology is not dependent on the amount of clinical material obtained. J Clin Pathol. 2004, 57: 193-195. 10.1136/jcp.2003.12914.PubMedCentralCrossRefPubMed
15.
Verkooijen HM, Peters JL, Schipper ME, Buskens E, Hendriks JH, Pijnappel RM, Peeters PH, Borel Rinkes IH, Mali WP, Holland R: Interobserver variability between general and expert pathologists during histopathological assessment of large-core needle and open biopsies of non-palpable lesions. Eur J Cancer. 2003, 39: 2187-2191. 10.1016/S0959-8049(03)00540-9.CrossRefPubMed
16.
de Roos MAJ, Pijnappel RM, Post WJ, de Vries J, Baas PC, Groote LD: Correlation between imaging and pathology in ductal carcinoma in situ of the breast. World J Surg Oncol. 2004, 2: 4-10.1186/1477-7819-2-4.PubMedCentralCrossRefPubMed
17.
Greenhough RB: Varying degree of malignancy in cancer of the breast. J Cancer Res. 1925, 9: 452-463.
18.
19.
20.
21.
22.
Elston CW: The assessment of histological differentiation in breast cancer. Aust N Z J. 1984, 54: 11-15.CrossRef
23.
Elston CW, Ellis IO: Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow up. Histopathology. 1991, 19: 403-410.CrossRefPubMed
24.
Harris JR, Connolly JL, Schnitt SJ, Silen W: The use of pathologic features in selecting the extent of surgical resection necessary for breast cancer patients treated by primary radiation therapy. Ann Surg. 1984, 201: 164-169.CrossRef
25.
Zafrani B, Vielh P, Fourquet A, Mosseri V, Durrand JC, Salmon RJ, Vilcoq JR: Conservative treatment of early breast: prognostic value of ductal in-situ and other pathological variables on local control and survival. Eur J Cancer. 1989, 25: 1645-1650.CrossRef
26.
Meyer JS, Rao BR, Stevens SC, White WL: Low incidence of oestrogen receptor in breast carcinomas with rapid rate of cellular proliferation. Cancer. 1977, 40: 2290-2298.CrossRefPubMed
27.
Bishop HM, Blamey RW, Elston CW, Haybittle JL, Nicholson RI, Griffiths K: Relationship of oestrogen receptor status to survival in breast cancer. Lancet. 1979, 2: 283-284. 10.1016/S0140-6736(79)90295-2.CrossRefPubMed
28.
Elston CW, Blamey RW, Johnson J, Bishop HM, Haybittle JL, Griffiths K: The relationship oestradiol receptors (ER) and histological tumour differentiation with prognosis in human primary breast carcinoma. In: Breast cancer-experimental and clinical aspects. Edited by: Mouridsen HT, Palshof R. 1980, Oxford: Pergamon Press, 59-62.
29.
Biopsy. In: Detection and treatment of breast cancer. Edited by: Fentiman IS. 1998, London: Martin Dunitz Ltd, 71-83.
30.
Yamamoto D, Yamada M, Okugawa H, Tanaka K: Predicting invasion in mammographically detected microcalcifcation: A preliminary report. World J Surg Oncol. 2004, 2: 8-10.1186/1477-7819-2-8.PubMedCentralCrossRefPubMed
31.
Greenall MJ: Cancer of the breast. In: Oxford Textbook of Surgery. Edited by: Morris PJ, Malt RA. 1994, Oxford University Press, 808-841.
Metadata
Title
Core biopsy as a tool in planning the management of invasive breast cancer
Authors
Amar Deshpande
Trivikram Garud
Simon D Holt
Publication date
01-12-2005
Publisher
BioMed Central
Published in
World Journal of Surgical Oncology / Issue 1/2005
Electronic ISSN: 1477-7819
DOI
https://doi.org/10.1186/1477-7819-3-1

Other articles of this Issue 1/2005

World Journal of Surgical Oncology 1/2005 Go to the issue

Review

Neck dissections: radical to conservative

Case report

Retroperitoneal myolipoma

Editorial

Neck dissection: an operation in evolution

Case report

A novel combination of multiple primary carcinomas: Urinary bladder transitional cell carcinoma, prostate adenocarcinoma and small cell lung carcinoma- report of a case and review of the literature

Case report

Adenocarcinoma in bladder diverticulum, metastatic from gastric cancer

Research

Neoadjuvant chemotherapy versus primary surgery in advanced ovarian carcinoma